At ISPOR Meeting, GfK Bridgehead Will Present New Findings, Perspectives On Key Issues for Health Marketplace

  At ISPOR Meeting, GfK Bridgehead Will Present New Findings, Perspectives On
  Key Issues for Health Marketplace

GfK Bridgehead will take part in 11 sessions at annual meeting of specialists
in pharmacoeconomics, patient outcomes

2013 Annual International Meeting of ISPOR

Business Wire

NEW YORK -- May 17, 2013

GfK Bridgehead will play a key role in the 2013 Annual International Meeting
of ISPOR (International Society for Pharmacoeconomics and Outcomes Research),
participating in 11 sessions focusing on how the health industry should
leverage new data sources to articulate the value of innovations for health
payers, economists, policy makers and others.

Experts from GfK Bridgehead – a division of GfK’s Health group – will present
new findings in such key areas as:

  *patient outcomes in a fee-for-service health marketplace
  *health economic modeling methods
  *quality metrics and costly hospitalizations
  *the effect of Massachusetts’ health reform act on patient outcomes
  *the cost impact of comprehensive STI screening
  *HTA and reimbursement decision making for diagnostics

          To access a guide to GfK’s sessions at the ISPOR meeting,
                                 click here.

“Innovators are challenged to navigate an increasingly cost-constrained
healthcare environment in markets around the globe,” said Susan Garfield,
Senior Vice President, Market Access, at GfK Bridgehead. “GfK will be
presenting several studies that showcase effective methods to navigate
existing challenges while keeping patient needs central.Our research also
highlights specific tools to articulate value to payers, HTAs, and hospital
purchasing decision-makers.”

The theme of this year’s ISPOR Annual Meeting – which will take place from May
18^th to 22^nd in New Orleans – is “Patient-Centered Outcomes: Focusing on the
Patient.” Since 1995, the society has grown to include over 13,000 members
internationally -- health care researchers, health technology developers and
assessors, regulators, health economists, health care policy makers, payers,
providers, educators and students.

About GfK

GfK is one of the world’s largest research companies, with more than 12,000
experts working to discover new insights into the way people live, think and
shop, in over 100 markets, every day. GfK is constantly innovating and using
the latest technologies and the smartest methodologies to give its clients the
clearest understanding of the most important people in the world: their
customers. In 2012,GfK’s sales amounted to EUR 1.51 billion.

To find out more, visit or follow GfK on Twitter:


GfK Marketing and Communications, Consumer Experiences North America
David Stanton, 908-875-9844
Vice President
Press spacebar to pause and continue. Press esc to stop.